DOJ throws support to Oscar in Florida Blue legal fight

An Oscar Health lawsuit alleging Florida Blue’s broker policy is anticompetitive shouldn’t be dismissed based on the McCarran-Ferguson Act, according to the Department of Justice.

Advertisement

In a statement of interest obtained by the Daily Business Review, the Justice Department said the McCarran-Ferguson Act, which exempts insurance business from most federal regulation, should not be used as a basis to dismiss the case.

Oscar Health sued Florida Blue in November 2018 over its exclusive broker policy, which Oscar argues excludes insurance brokers who work with Florida Blue from selling policies of other insurers. Oscar claimed that Florida Blue’s policy — coupled with its market dominance — allows the insurer to effectively operate as a monopoly.

More articles on payers:
Judge steps down from UnitedHealth case over ‘immoral’ denial of cancer treatment
House Democrats unveil Medicare expansion plan: 8 things to know
Humana posts $566M profit in Q1

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Payer

Advertisement

Comments are closed.